Dextrose 5% and Potassium Chloride 0.224% in Plastic Container

Potassium Chloride in Dextrose Injection is indicated as a source of water, electrolytes and calories. Potassium Chloride in Dextrose Injection is indicated as a source of water, electrolytes and calories. (1)

Potassium Chloride in Dextrose Injection is contraindicated in patients with:

• known hypersensitivity to potassium chloride and/or dextrose [see Warnings and Precautions 5.1) ]
• clinically significant hyperkalemia [see Warnings and Precautions (5.2) ]
• clinically significant hyperglycemia [see Warnings and Precautions (5.3) ]
• Known hypersensitivity to potassium chloride or dextrose (4 , 5.1 )
• Clinically significant hyperkalemia (4 , 5.2)
• Clinically significant hyperglycemia (4 , 5.3)

• Hypersensitivity Reactions : monitor for signs and symptoms and discontinue infusion if reactions occur. (5.1)
• Hyperkalemia : May result in cardiac arrhythmias. Avoid use in patients with, or at risk for, hyperkalemia. If use cannot be avoided, use a product with a low amount of potassium chloride, infuse slowly and monitor serum potassium concentrations and ECGs. (5.2)
• Hyperglycemia or Hyperosmolar Hyperglycemic State : Monitor blood glucose and administer insulin as needed. (5.3 , 8.4)
• Hyponatremia : Avoid in patients with or at risk for hyponatremia. If use cannot be avoided, monitor serum sodium concentrations. (5.4 , 8.4)
• Hypokalemia: Avoid in patients with or at risk for hypokalemia. If use cannot be avoided, monitor serum potassium levels. (5.5)
• Fluid Overload : Avoid in patients with or at risk for fluid and/or solute overloading. If use cannot be avoided, monitor daily fluid balance and electrolyte, concentrations and acid-base balance, as needed and especially during prolonged use. (5.6)
• Refeeding Syndrome : Monitor severely undernourished patients and slowly increase nutrient intake. (5.7)